For NGFR haplotypes, among ApoE ε4 non-carriers, diabetic patients carrying minor Hap1 GCGCG had a decreased risk of AD (1 or 2 copies vs. 0 copies: OR = 0.28, 95% CI = 0.08-0.97, Table 6). This evidence concerns the gene NGFR and Alzheimer disease.